Brief: Neurosense Completes Enrollment In Phase 2B Als Clinical Trial

Neurosense Therapeutics

15/05/2023 14:06

Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE COMPLETES ENROLLMENT IN PHASE 2B ALS CLINICAL
TRIAL
    * NEUROSENSE THERAPEUTICS LTD - TOPLINE RESULTS EXPECTED Q4
2023

Source text for Eikon:  ID:nPn6brm9a 
Further company coverage:  NRSN.O